2022
DOI: 10.1590/1516-3180.2021.0200.r1.03052021 View full text |Buy / Rent full text
|
|

Abstract: BACKGROUND: Coronavirus disease 2019 (COVID-19) is an ongoing global health threat. However, currently, no standard therapy has been approved for the disease. OBJECTIVES: To evaluate the clinical effectiveness of convalescent plasma (CP) in patients with acute respiratory distress syndrome (ARDS) due to COVID-19.

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
1
0

Publication Types

Select...

Relationship

0
0

Authors

Journals